Fetal Liver Cells Mononuclear Cells 13-24 Weeks Gestation

Cat.No.: CSC-C4499X

Species: Human

Source: Liver

Cell Type: Mononuclear

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4499X
Description
Fetal liver is dissociated in an asceptic manner, followed by density separation to enrich the mononuclear cells. The enriched cells are frozen using our optimized cryopreservation medium. Fetal liver Mononuclear Cells can also be used for RNA extraction and cDNA production.
Species
Human
Source
Liver
Cell Type
Mononuclear
Disease
Normal
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Fetal liver mononuclear cells (FLMNCs) play a crucial role in the development of the immune system and embryonic hematopoiesis. Morphologically, these cells typically appear round or oval. The mononuclear precursor cells have larger nuclei and less cytoplasm; immature mononuclear cells exhibit more cytoplasm, which is light blue in color; and mature mononuclear cells contain an abundance of cytoplasm and lysosomes. Under the microscope, the distinctive morphological features of these cells are clearly discernible.

In the 13-24 weeks period of fetal liver development, as the fetus continues to mature, hematopoietic functions become more refined and established across multiple organs. During this stage, the bone marrow gradually takes over as the primary organ of hematopoiesis, while the liver's role shifts towards a more collaborative function in hematopoiesis and immunity. At this point, the number of mononuclear cells in the liver increases, and they become more diverse in terms of both types and functions, encompassing mononuclear precursor cells and mature functional mononuclear. These cells can further differentiate into macrophages, exhibiting enhanced phagocytic capabilities and more complex immune responses. They progressively participate in intrahepatic immune regulation, pathogen defense, and assist in local tissue repair and the maintenance of organ homeostasis.

FLMNCs have wide applications in scientific research, primarily in hematopoiesis studies. They are instrumental in exploring the role of mononuclear cells within the hepatic hematopoietic microenvironment, aiding in the understanding of hematopoietic stem cell development and function. Moreover, these cell lines are pivotal in the study of fetal immune system development, providing fundamental insights into immune system maturation.

GC-macrophages Share Characteristics with CD163+ Macrophages Found in Human Bone Marrow and Fetal Liver

Erythropoiesis in human bone marrow (BM) and fetal liver (FL) occurs within erythroblastic islands, comprising a central macrophage surrounded by erythroid cells at different maturation stages. Macrophages are crucial in this process, but existing models are limited to BM harvesting or complex genetic modifications. Previous studies showed that cultured monocytes can differentiate into macrophages that support erythropoiesis and hematopoietic stem and progenitor cells (HSPC) survival, resembling BM and FL macrophages. Heideveld et al. aimed to establish a convenient in vitro model to investigate erythroid-macrophage interactions by differentiating monocytes into anti-inflammatory M2 macrophages (GC-macrophages) using glucocorticoids, to mimic erythroblastic islands in vitro.

They analyzed whether macrophages in primary erythropoietic organs (human fetal liver (FL) and bone marrow (BM)) share phenotypic characteristics with GC-macrophages. During weeks 15-22, the FL is heavily involved in erythropoiesis. FL exhibits increased CD71+CD235pro-erythroblasts (Fig. 1A and B). To prevent free immunogenic pyrenocytes and support erythroid cells in embryos, FL contains substantial erythroblastic islands and macrophages, showing a 6.5-fold increase in CD163+ macrophages compared to BM (Fig. 1C and D). Both FL and BM macrophages express high CD163 and CD14, with CD163+ FL macrophages showing higher CD16 expression and CD163+ BM macrophages higher CXCR4. GC-macrophages mimic both BM and FL macrophages, showing similarities to BM macrophages (CD16 and CXCR4) and FL macrophages (CD206). Unstimulated cells lack VCAM1 and display low CD206, CD163, CD14, and CD16 (Fig. 1E and F). Both BM and FL CD163+ macrophages bind erythroid cells, indicating CD163 marks erythroid-supporting macrophages. FL macrophages interact more with CD71+CD235a+ cells. The phenotypic similarity and erythroid cluster formation of BM, FL, and GC-macrophages suggest GC-macrophages share key characteristics with in vivo erythroid-supporting macrophages and could serve as an in vitro model for studying macrophage support in erythropoiesis.

CD163<sup>+</sup> macrophage populations in human bone marrow and fetal liver.Fig. 1. CD163+ macrophage populations in human BM and FL (Heideveld E, Hampton-O'Neil LA, et al., 2018).

HMGA2 is Preferentially Expressed in the Most Immature Fractions of Human

hematopoietic stem and progenitor cells (HSPCs)

Hematopoietic stem cells (HSCs) are crucial for generating differentiated blood cells throughout life. Regulation of their fate is controlled by various DNA-binding factors. High-mobility group AT hook 2 (HMGA2) is a nonhistone chromosomal-binding protein that has shown significant roles in regulating stem and progenitor cells, influencing gene expression, chromatin conformation, and recruiting factors for transcription. Kumar et al. aimed to elucidate the role of HMGA2 in the regulation of human HSCs by investigating its effects on proliferation and differentiation using both gain-of-function and loss-of-function approaches.

Mononuclear cells were isolated from neonatal cord blood (CB) and adult bone marrow (BM) using density gradient separation, followed by CD34+ cell isolation with anti-CD34 magnetic beads along with human fetal liver mononuclear cells (16 weeks). CB CD34 cells were then stained with CD34-fluorescein isothiocyanate, CD38-phycoerythrin, CD90-allophycocyanin, CD45RA-V450 for HSCs sorting. Results showed higher HMGA2 expression in the most primitive hematopoietic fractions (HSCs and multipotent progenitors) than in more committed progenitors across all three stages (Fig. 2A-C). Additionally, HSCs from CB and fetal liver had significantly higher HMGA2 expression compared to adult BM HSCs (Fig. 2D), consistent with previously observed fetal stage-specific expression in murine hematopoiesis. Since HMGA2 is posttranscriptionally regulated by Let-7 microRNAs, they validated the expression at the protein level, confirming robust expression in CB-derived HSCs and MPPs but almost undetectable in more mature cells (Fig. 2E). This protein analysis further showed that HSCs had substantially higher HMGA2 expression compared with MPPs that lack self-renewal potential, indicating HMGA2's role in regulating HSC function.

Selective expression of HMGA2 in the early-stage human hematopoietic cell population.Fig. 2. Preferential expression of HMGA2 within the primitive compartment of human hematopoietic cells (Kumar P, Beck D, et al., 2019).

Ask a Question

Write your own review

For research use only. Not for any other purpose.